Sanyou Medical 三友医疗
8 significant filings since 29 May 2026: 6 on buyback, 1 on guarantee or financial assistance and 1 on dividend. The latest, on 12 Sep 2026: 关于为控股公司提供担保的公告.
自 29 May 2026 起有 8 份重大公告：buyback 6 份、guarantee or financial assistance 1 份、dividend 1 份。最新一份（12 Sep 2026）：关于为控股公司提供担保的公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 4 Jan 2021 | 信达证券 | 杨松,张雪 | Buy 买入 | ▼ | Outperform 增持 |
| 26 Oct 2020 | 信达证券 | 杨松,张雪 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 中银证券 | 刘恩阳,苏雪儿 | Buy 买入 | 1 Sep 2026 | 3 | — |
| 华安证券 | 谭国超,钱琨 | Buy 买入 | 29 Oct 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 4 reports. 每行为该券商近十二个月的最新研报；4 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。